| Orginal Article |
|
|
|
|
| Advances in Research of Oral Anticancer Drug Nanocarrier |
Xiao-qian PAN1,Xiang-yuan XIONG1,2,**( ),Yan-chun GONG2,Zi-ling LI2,Yu-ping LI2 |
1 School of Pharmaceutical Sciences, Jiangxi Science and Technology Normal University,Nanchang 330013,China
2 School of Life Sciences, Jiangxi Science and Technology Normal University,Nanchang 330013,China |
|
|
|
Abstract Cancer chemotherapy and the patient’s life will be very convenient if oral administration of anti-cancer drugs can be achieved. For most anti-cancer drugs, their bioavailability and treatment efficiency will be decreased by oral administration, due to the gastrointestinal barrier. So it is important to find an effective drug carrier for oral administration of anticancer drugs. The emergence of nanotechnology, led to the development of nano-drugs. Therefor a great breakthrough has been achieved for oral administration of anti-cancer drugs. The research progress of different materials, including synthetic polymer materials, natural macromolecular materials and liposomes as oral anticancer drug carriers, including their in vivo or in vitro studies has been reviewed.
|
|
Received: 22 April 2018
Published: 12 October 2018
|
|
Corresponding Authors:
Xiang-yuan XIONG
E-mail: xyxiong@gmail.com
|
|
|
| [1] |
Guo Y, Chu M, Tan S , et al. Chitosan-g-tpgs nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Molecular Pharmaceutics, 2014,11(1):59-70.
doi: 10.1021/mp400514t
|
|
|
| [2] |
Feng S S, Zhao L Y, Tang J T . Nanomedicine for oral chemotherapy. Nanomedicine, 2011,6(3):407-410.
doi: 10.2217/nnm.11.7
|
|
|
| [3] |
Li P Y, Lai P S, Hung W C , et al. Vitamin e tpgs used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (taxol ®) . Journal of Controlled Release, 2002,80(1):129-144.
doi: 10.1016/S0168-3659(02)00025-1
|
|
|
| [4] |
Feng S S, Mei L, Anitha P , et al. Poly(lactide)-vitamin e derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel. Biomaterials, 2009,30(19):3297-3306.
doi: 10.1016/j.biomaterials.2009.02.045
|
|
|
| [5] |
Chen H B, Zheng Y, Tian G , et al. Oral delivery of dmab-modified docetaxel-loaded plga-tpgs nanoparticles for cancer chemotherapy. Nanoscale Research Letters, 2010,6(1):4-14.
|
|
|
| [6] |
Thanki K, Gangwal R P, Sangamwar A T , et al. Oral delivery of anticancer drugs: Challenges and opportunities. Journal of Control Release, 2013,170(1):15-40.
doi: 10.1016/j.jconrel.2013.04.020
|
|
|
| [7] |
Ensign L M, Cone R, Hanes J . Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Advanced Drug Delivery Reviews, 2012,64(6):557-570.
doi: 10.1016/j.addr.2011.12.009
|
|
|
| [8] |
Lai S K, Wang Y Y, Hanes J . Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Advance Drug Delivery Reviews, 2009,61(2):158-171.
doi: 10.1016/j.addr.2008.11.002
|
|
|
| [9] |
Zhao L Y, Feng S S . Enhanced oral bioavailability of paclitaxel formulated in vitamin e-tpgs emulsified nanoparticles of biodegradable polymers: In vitro and in vivo studies. Journal of Pharmaceutical Sciences, 2010,99(8):3552-3560.
doi: 10.1002/jps.22113
|
|
|
| [10] |
Gottesman M M, Fojo T, Bates S E . Multidrug resistance in cancer: Role of atp-dependent transporters. Nature Reviews Cancer, 2002,2(1):48-58.
doi: 10.1038/nrc706
|
|
|
| [11] |
Siarheyeva A, Lopez J J, Glaubitz C . Localization of multidrug transporter substrates within model membranes. Biochemistry, 2006,45(19):6203-6211.
doi: 10.1021/bi0524870
|
|
|
| [12] |
Kinoshita R, Ishima Y , Chuang V T G , et al. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of epr effect and albumin-protein interactions using snitrosated human serum albumin dimer. Biomaterials, 2017,140:162-169.
doi: 10.1016/j.biomaterials.2017.06.021
|
|
|
| [13] |
Beloqui A, des Rieux A, Préat V . Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier. Advanced Drug Delivery Reviews, 2016,106:242-255.
doi: 10.1016/j.addr.2016.04.014
|
|
|
| [14] |
Li Z, Jiang H, Xu C , et al. A review: Using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals. Food Hydrocolloids, 2015,43:153-164.
doi: 10.1016/j.foodhyd.2014.05.010
|
|
|
| [15] |
Pridgen E M, Alexis F, Kuo T T , et al. Transepithelial transport of fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Science Translational Medicine, 2013,5(213):1-8.
|
|
|
| [16] |
Agueros M, Zabaleta V, Espuelas S , et al. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. Journal of Control Release, 2010,145(1):2-8.
doi: 10.1016/j.jconrel.2010.03.012
|
|
|
| [17] |
Win K Y, Feng S S . Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 2005,26(15):2713-2722.
doi: 10.1016/j.biomaterials.2004.07.050
|
|
|
| [18] |
Tao W, Zeng X, Liu T , et al. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core plga-tpgs diblock copolymer for breast cancer therapy. Acta Biomaterialla, 2013,9(11):8910-8920.
doi: 10.1016/j.actbio.2013.06.034
|
|
|
| [19] |
Collnot E M, Baldes C, Schaefer U F , et al. Vitamin e tpgs p-glycoprotein inhibition mechanism: Influence on conformational flexibility, intracellular atp levels, and role of time and site of access. Molecular Pharmaceutics, 2010,7(3):642-651.
doi: 10.1021/mp900191s
|
|
|
| [20] |
Zhu H, Chen H, Zeng X , et al. Co-delivery of chemotherapeutic drugs with vitamin e tpgs by porous plga nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials, 2014,35(7):2391-2400.
doi: 10.1016/j.biomaterials.2013.11.086
|
|
|
| [21] |
Roger E, Kalscheuer S, Kirtane A , et al. Folic acid functionalized nanoparticles for enhanced oral drug delivery. Molecular Pharmaceutics, 2012,9(7):2103-2010.
doi: 10.1021/mp2005388
|
|
|
| [22] |
Pandey S K, Ghosh S, Maiti P , et al. Therapeutic efficacy and toxicity of tamoxifen loaded pla nanoparticles for breast cancer. International Journal of Biological Macromolecules, 2015,72:309-319.
doi: 10.1016/j.ijbiomac.2014.08.012
|
|
|
| [23] |
Zhang Z P, Feng S S . Self-assembled nanoparticles of poly(lactide)-vitamin e tpgs copolymers for oral chemotherapy. International Journal of Pharmaceutics, 2006,324(2):191-198.
doi: 10.1016/j.ijpharm.2006.06.013
|
|
|
| [24] |
Tobío M, Sánchez A, Vila A , et al. The role of peg on the stability in digestive fluids and in vivo fate of peg-pla nanoparticles following oral administration. Colloids and Surfaces B -Biointerfaces, 2000,18(3):315-323.
doi: 10.1016/S0927-7765(99)00157-5
|
|
|
| [25] |
Zhao T J, Chen H Z, Yang L X , et al. Ddab-modified tpgs-b-(pcl-ran-pga) nanoparticles as oral anticancer drug carrier for lung cancer chemotherapy. NANO: Brief Reports and Reviews, 2013,8(2):1350014-1350024.
|
|
|
| [26] |
Huarte J, Espuelas S, Lai Y , et al. Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles. International Journal of Pharmaceutics, 2016,506(1):116-128.
doi: 10.1016/j.ijpharm.2016.04.045
|
|
|
| [27] |
Yoncheva K, Lizarraga E, Irache J M . Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): Preparation and evaluation of their bioadhesive properties. European Journal of Pharmaceutical Sciences, 2005,24(5):411-419.
doi: 10.1016/j.ejps.2004.12.002
|
|
|
| [28] |
Zabaleta V, Ponchel G, Salman H , et al. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. European Journal of Pharmaceutics and Biopharmaceutics, 2012,81(3):514-523.
doi: 10.1016/j.ejpb.2012.04.001
|
|
|
| [29] |
Trickler W J, Nagvekar A A, Dash A K . A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSciTech, 2008,9(2):486-493.
doi: 10.1208/s12249-008-9063-7
|
|
|
| [30] |
Feng C, Wang Z, Jiang C , et al. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: In vitro and in vivo evaluation. International Journal of Pharmaceutics, 2013,457(1):158-167.
doi: 10.1016/j.ijpharm.2013.07.079
|
|
|
| [31] |
Mo R, Jin X, Li N , et al. The mechanism of enhancement on oral absorption of paclitaxel by n-octyl-o-sulfate chitosan micelles. Biomaterials, 2011,32(20):4609-4620.
doi: 10.1016/j.biomaterials.2011.03.005
|
|
|
| [32] |
Zhang C, Qu G W, Sun Y J , et al. Pharmacokinetics, biodistribution, efficacy and safety of n-octyl-o-sulfate chitosan micelles loaded with paclitaxel. Biomaterials, 2008,29(9):1233-1241.
doi: 10.1016/j.biomaterials.2007.11.029
|
|
|
| [33] |
Li J, Huang P, Chang L , et al. Tumor targeting and ph-responsive polyelectrolyte complex nanoparticles based on hyaluronic acid-paclitaxel conjugates and chitosan for oral delivery of paclitaxel. Macromolecular Research, 2013,21(12):1331-1337.
doi: 10.1007/s13233-013-1171-x
|
|
|
| [34] |
Ryan C W, Fleming G F, Janisch L , et al. A phase i study of liposomal doxorubicin (doxil) with topotecan. American Journal of Clinical Oncology, 2000,23(3):297-300.
doi: 10.1097/00000421-200006000-00019
|
|
|
| [35] |
Chen H, Wu J, Sun M , et al. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. Journal of Liposome Research, 2012,22(2):100-109.
doi: 10.3109/08982104.2011.621127
|
|
|
| [36] |
Astete C E, Sabliov C M . Synthesis and characterization of plga nanoparticles. Journal of Biomaterials Science(Polymer Edition), 2006,17(3):247-289.
doi: 10.1163/156856206775997322
|
|
|
| [37] |
Mei L, Zhang Z P, Zhao L Y , et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Advanced Drug Delivery Reviews, 2013,65(6):880-890.
doi: 10.1016/j.addr.2012.11.005
|
|
|
| [38] |
Xie X X, Tao Q, Zou Y N , et al. Plga nanoparticles improve the oral bioavailability of curcumin in rats: Characterizations and mechanisms. Journal of Agricultural and Food Chemistry, 2011,59(17):9280-9289.
doi: 10.1021/jf202135j
|
|
|
| [39] |
Palacio J, Orozco V H, López B L . Effect of the molecular weight on the physicochemical properties of poly(lacticacid) nanoparticles and on the amount of ovalbumin adsorption. J Braz Chem Soc, 2011,22(12):2304-2311.
|
|
|
| [40] |
Khutoryanskiy V V . Advances in mucoadhesion and mucoadhesive polymers. Macromolecular Bioscience, 2011,11(6):748-764.
doi: 10.1002/mabi.201000388
|
|
|
| [41] |
Li J, Sabliov C . Pla/plga nanoparticles for delivery of drugs across the blood-brain barrier. Nanotechnology Reviews, 2013,2(3):245-257.
|
|
|
| [42] |
Muthu M S, Singh S . Studies on biodegradable polymeric nanoparticles of risperidone: In vitro and in vivo evaluation. Nanomedicine, 2008,3(3):305-319.
doi: 10.2217/17435889.3.3.305
|
|
|
| [43] |
Chawla J S, Amiji M M . Biodegradable poly(o-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. International Journal of Pharmaceutics, 2002,249(1):127-138.
doi: 10.1016/S0378-5173(02)00483-0
|
|
|
| [44] |
Gou M L, Wei X W, Men K , et al. Pcl/peg copolymeric nanoparticles: Potential nanoplatforms for anticancer agent delivery. Current Drug Targets, 2011,12(8):1131-1150.
doi: 10.2174/138945011795906642
|
|
|
| [45] |
Kumar N, Langer R S, Domb A J . Polyanhydrides: An overview. Advanced Drug Delivery Reviews, 2002,54(7):889-910.
doi: 10.1016/S0169-409X(02)00050-9
|
|
|
| [46] |
Wang Y, Li P, Chen F , et al. A novel ph-sensitive carrier for the delivery of antitumor drugs: Histidine-modified auricularia auricular polysaccharide nano-micelles. Scientific Reports, 2017,7(1):1-10.
doi: 10.1038/s41598-016-0028-x
|
|
|
| [47] |
Kolanthai E, Abinaya Sindu P, Thanigai Arul K , et al. Agarose encapsulated mesoporous carbonated hydroxyapatite nanocomposites powder for drug delivery. Journal of Photochemistry and Photobiology B: Biology, 2017,166:220-231.
doi: 10.1016/j.jphotobiol.2016.12.005
|
|
|
| [48] |
Anandhakumar S, Krishnamoorthy G, Ramkumar K M , et al. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery. Materials Science and Engineering: C, 2017,70:378-385.
doi: 10.1016/j.msec.2016.09.003
|
|
|
| [49] |
Palmberger T F, Hombach J, Bernkop-Schnurch A . Thiolated chitosan: Development and in vitro evaluation of an oral delivery system for acyclovir. International Journal of Pharmaceutics, 2008,348(1-2):54-60.
doi: 10.1016/j.ijpharm.2007.07.004
|
|
|
| [50] |
Kamaly N, Yameen B, Wu J , et al. Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release. Chemical Reviews, 2016,116(4):2602-2663.
doi: 10.1021/acs.chemrev.5b00346
|
|
|
| [51] |
Thanou M, Verhoef J C, Junginger H E . Oral drug absorption enhancement by chitosan and its derivatives. Advanced Drug Delivery Reviews, 2001,52(2):117-126.
doi: 10.1016/S0169-409X(01)00231-9
|
|
|
| [52] |
Kumar M N, Muzzarelli R A, Muzzarelli C , et al. Chitosan chemistry and pharmaceutical perspectives. Chemical Reviews, 2004,104(12):6017-6084.
doi: 10.1021/cr030441b
|
|
|
| [53] |
Hosseinzadeh H, Atyabi F, Dinarvand R , et al. Chitosan-pluronic nanoparticles as oral delivery of anticancer gemcitabine: Preparation and in vitro study. International Journal of Nanomedicine, 2012,7(1):1851-1863.
doi: 10.2217/nnm.12.70
|
|
|
| [54] |
Jiang L Q, Li X M, Liu L R , et al. Thiolated chitosan-modified pla-pcl-tpgs nanoparticles for oral chemotherapy of lung cancer. Nanoscale Research Letters, 2013,8(1):66-77.
doi: 10.1186/1556-276X-8-66
|
|
|
| [55] |
Kogan G, Šoltés L, Stern R , et al. Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett, 2007,29(1):17-25.
|
|
|
| [56] |
Sudha P N, Rose M H . Beneficial effects of hyaluronic acid. Advances in Food and Nutrition Research, 2014,72:137-176.
doi: 10.1016/B978-0-12-800269-8.00009-9
|
|
|
| [57] |
Jiao Y, Pang X, Zhai G . Advances in hyaluronic acid-based drug delivery systems. Current Drug Targets, 2016,17(6):720-730.
doi: 10.2174/1389450116666150531155200
|
|
|
| [58] |
Ghosh S C, Alpay S N, Klostergaard J . Cd44: A validated target for improved delivery of cancer therapeutic. Expert Opinion on Therapeutic Targets, 2012,16(7):635-650.
doi: 10.1517/14728222.2012.687374
|
|
|
| [59] |
Medina O P, Zhu Y, Kairemo K . Targeted liposomal drug delivery in cancer. Current Pharmaceutical Design, 2004,10(24):2981-2989.
doi: 10.2174/1381612043383467
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
